Ephrine Nose Drops Solution/ Drops
Product Images NDC 0363-2023

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ephrine Nose Drops (NDC 0363-2023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Walgreens, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton Ephrine Dl)

Carton (Carton Ephrine Dl)
This is a Drug Facts label for a medication intended for the temporary relief of nasal congestion due to the common cold, hay fever, upper respiratory allergies, and sinus congestion and pressure. The medication contains 1% of the active ingredient Naphazoline Hydrochloride and is meant for use only as directed. The directions for use vary depending on age and warn against using the product more than directed or for more than three days. The label includes warnings and precautions, such as asking a doctor before use if you have heart disease, high blood pressure, thyroid disease, diabetes, or trouble urinating due to an enlarged prostate gland. If pregnant or breastfeeding, it is recommended to ask a health professional before use. The product should be kept out of reach of children and may cause temporary discomfort such as burning, stinging, sneezing, or an increase in nasal discharge. The product is distributed by Walgreen Co.*
FDA Label Image

Bottle (Label Ephrine Dl)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.